Electroporation Instrument Market, by Product Type (Systems and Accessories (Electrodes, Cuvettes, Chambers, Kits, Others)), by Application (Protein Production, Drug Delivery, Biomedical Research, Gene Therapy, Ablation (Oncology, Cardiology, Others), Oth

Electroporation Instrument Market, by Product Type (Systems and Accessories (Electrodes, Cuvettes, Chambers, Kits, Others)), by Application (Protein Production, Drug Delivery, Biomedical Research, Gene Therapy, Ablation (Oncology, Cardiology, Others), Others), By Mode (In-Vitro/Clinical and In-Vivo), by End user (Biopharmaceutical, Companies, Hospitals, Research & Academic, Institutes, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Electroporation is a useful molecular biology technique that allows for non-chemical transformation of bacteria and yeasts as well as transfection of tissue culture cells (e.g. mammalian cells). Electroporation systems deliver short bursts of a high-intensity electric field to cells. The electrical field makes the cell membrane more permeable. As a result, chemicals such as drugs and genetic material can pass through the cell membrane, which would otherwise be impermeable. Due to its ease of use and efficacy, electroporation is a popular method for introducing foreign genes into target cells. In addition to direct gene introduction, electroporation allows for the direct transfer of plasmids between cells or species—for instance, from bacteria to yeast. Extensive research is ongoing on the use of electroporation to deliver medicines and vaccines directly to the cells of living organisms. Electroporation systems are commonly used for the treatment of cancer through vaccine delivery, gene delivery or drug delivery that is electrochemotherapy, for instance bleomycin Vaccine delivery can also be used for treatment of infectious disease such as Human immunodeficiency virus (HIV).

Market Dynamics

Key players operating in the global electroporation instruments market are focusing on growth strategies such as rebranding and agreements which is expected to drive the market growth during the forecast period. For instance, The Company is now operating as Eppendorf SE with immediate effect. Eppendorf AG was restructured into a European Company (Societas Europaea, SE) under the name Eppendorf SE, effective October 19, 2021. This change of legal form to an SE does not affect any existing business relationships with their partners; existing contractual relationships in particular continue unchanged. Moreover, On July 15, 2022, MaxCyte, Inc. had announced the Strategic Platform License (SPL) signed with LG Chem Ltd., a global diversified chemical company .Under the terms of the agreement, LG Chem will receive non-exclusive clinical and commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform. In return, MaxCyte is entitled to platform license fees and program-related revenues.

Key features of the study:

• This report provides in-depth analysis of the global electroporation instruments market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022 – 2030).
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
• The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global electroporation instruments market.
• The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global electroporation instruments market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global electroporation instruments market.

Detailed Segmentation:

• Global Electroporation Instrument Market, By Product Type:
• Systems
• Accessories
• Electrodes
• Cuvettes
• Chambers
• Kits
• Others
• Global Electroporation Instruments Market, By Application:
• Protein Production
• Drug Delivery
• Biomedical Research
• Gene Therapy
• Ablation
• Oncology
• Cardiology
• Others
• Others
• Global Electroporation Instruments Market , By Mode:
• In-vitro/clinical
• In-vivo
• Global Electroporation Instruments Market, By End User:
• Biopharmaceutical Companies
• Hospitals
• Research & Academic Institutes
• Others
• Global Electroporation Instruments Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country:
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country:
• Israel
• GCC
• Rest of Middle East
• Africa
• By Country:
• South Africa
• North Africa
• Central Africa
• Company Profiles:
• Bio-Rad Laboratories, Inc.*
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Thermo Fisher Scientific Inc.
• BEX Co. Ltd.
• Celetrix LLC,
• Gamma Biosciences
• Merck KGaA,
• Eppendorf AG
• MaxCyte, Inc.
• BEX CO.,LTD.
• Lonza
• Altogen Biosystems
• Ala Scientific Instruments, Inc.
• BioEra Life Sciences Pvt. Ltd.
• Ichor Medical Systems

“*” marked represents similar segmentation in other categories in the respective section.